BENZEDREX 09-19-2014- propylhexedrine inhalant 
BF ASCHER AND CO INC

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Benzedrex

Active ingredient................. Purpose

Propylhexedrine 250 mg......Nasal decongestant

Uses

For the temporarily relief of nasal congestion due to a cold, hay fever, or other upper respiratory allergies (allergic rhinitis).

Uses

Temporarily relieves nasal congestion due to a cold, hay fever, or other upper respiratory allergies (allergic rhinitis).

Warnings

Do not use this product for more than three days.

Stop use and consult a doctor if symptoms persist.

If pregnant or breast-feeding, ask a health professional before use.

Keep this and all drugs out of reach of children. In case of overdose or ingestion of contents, get medical help or contact a poison control center immediately.

Directions

Directions

Other information

Inactive ingredients

lavender oil, menthol

Questions?

Call 1-800-324-1880, 7:30am - 4:00pm Central, Mon. - Fri., or visit us at www.bfascher.com

Benzedrex

BENZEDREX  09-19-2014
propylhexedrine inhalant
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0225-0610
Route of AdministrationNASAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
PROPYLHEXEDRINE (UNII: LQU92IU8LL) (PROPYLHEXEDRINE - UNII:LQU92IU8LL) PROPYLHEXEDRINE250 mg
Inactive Ingredients
Ingredient NameStrength
LAVENDER OIL (UNII: ZBP1YXW0H8)  
MENTHOL (UNII: L7T10EIP3A)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0225-0610-231 in 1 INHALER; Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.)09/19/201402/28/2025
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalM01209/19/201402/28/2025
Labeler - BF ASCHER AND CO INC (003854403)

Revised: 7/2023
Document Id: 00d95376-5745-3c48-e063-6394a90a7fbc
Set id: 03a8ef3c-a808-6208-e054-00144ff8d46c
Version: 5
Effective Time: 20230719
 
BF ASCHER AND CO INC